Medtronic PLC (MDT) Actualités

Medtronic announces CMS national coverage analysis for Symplicity™ Spyral Renal Denervation System

Medtronic announces CMS national coverage analysis for Symplicity™ Spyral Renal Denervation System PR...

Medtronic achieves CE Mark approval for BrainSense™ Adaptive deep brain stimulation and Electrode Identifier, a groundbreaking advance in personalized, sensing-enabled care for people with Parkinson's through innovative brain-computer interface technolog

Medtronic achieves CE Mark approval for BrainSense™ Adaptive deep brain stimulation and Electrode Identifier...

Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference

Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference PR Newswire GALWAY...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Medtronic announces cash dividend for third quarter of fiscal year 2025

Medtronic announces cash dividend for third quarter of fiscal year 2025 PR Newswire GALWAY, Ireland, Dec. 5...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Medtronic receives FDA clearance for new InPen™ app, paving the way for its Smart MDI system launch with Simplera™ CGM

Medtronic receives FDA clearance for new InPen™ app, paving the way for its Smart MDI system launch with...

Form 8-K - Current report

Medtronic reports second quarter fiscal 2025 financial results

Medtronic reports second quarter fiscal 2025 financial results PR Newswire GALWAY, Ireland, Nov. 19, 2024...

Medtronic to announce financial results for its second quarter of fiscal year 2025

Medtronic to announce financial results for its second quarter of fiscal year 2025 PR Newswire GALWAY...

CMS grants Transitional Pass-Through Payment for Medtronic Symplicity Spyral™ renal denervation catheter

CMS grants Transitional Pass-Through Payment for Medtronic Symplicity Spyral™ renal denervation catheter PR...

SPYRAL HTN-ON MED study shows significant, consistent, long-term blood pressure lowering effect at two years

SPYRAL HTN-ON MED study shows significant, consistent, long-term blood pressure lowering effect at two...

A new paradigm in electrophysiology: Medtronic receives FDA approval of Affera™ Mapping and Ablation System and Sphere-9™ Catheter

A new paradigm in electrophysiology: Medtronic receives FDA approval of Affera™ Mapping and Ablation System...